← Eichor
Study identifier: NCT06738654 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Application of Single-Port Robot-Assisted Breast-Conserving Surgery Via Axillary Approach for Breast Cancer.

Condition: Invasive Breast Carcinoma  ·  Sponsor: Xu Yan

PhaseNA
Planned participants64
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

Evaluate the safety,feasibility and quality of life(QoL)of single-port robotic surgery in breast-conserving surgery, compare and analyze the advantages and disadvantages of single-port robotic surgery and open surgery in terms of complications, postoperative complications, perioperative recovery effects, and safety in breast cancer breast-conserving surgery, in order to select a more effective and safe surgical method. Subjects who meet the inclusion criteria will enter the research process, with surgery including SPr-breast-conserving surgery or open-breast-conserving surgery, and the choice of the two surgical methods is based on the patient's financial situation and the availability of equipment;

This description comes directly from the study's public registry record.

Talk to the study team

yan xu Xu, Doctor  ·  023-68729250  ·  xy931@163.com

Always discuss trial participation with your own doctor first.

Locations (2)

Aramy medical center.Chongqing, Chongqing Municipality, ChinaNot Yet Recruiting
Army Medical CenterChongqing, Chongqing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06738654